10x Genomics (TXG) had its price target raised by Stifel Nicolaus from $20.00 to $25.00. They now have a "buy" rating on the stock.
10x Genomics (NASDAQ:TXG) had its "neutral" rating reaffirmed by analysts at UBS Group AG.
10x Genomics to Participate in the 46th Annual TD Cowen Health Care Conference
10x Genomics (NASDAQ:TXG) had its "hold" rating reaffirmed by analysts at TD Cowen.
10x Genomics (NASDAQ:TXG) was given a new $17.00 price target on by analysts at Deutsche Bank Aktiengesellschaft. They now have a "hold" rating on the stock.